[EN] COMPOUNDS WHICH SELECTIVELY MODULATE THE CB2 RECEPTOR<br/>[FR] COMPOSÉS QUI MODULENT SÉLECTIVEMENT LE RÉCEPTEUR CB2
                        
                            
                                申请人:BOEHRINGER INGELHEIM INT
                            
                            
                                公开号:WO2010147792A2
                            
                            
                                公开(公告)日:2010-12-23
                            
                            Compounds of formula (I) are disclosed. Compounds according to the invention bind to and are agonists, antagonists or inverse agonists of the CB2 receptor, and are useful for treating inflammation. Those compounds which are agonists are additionally useful for treating pain.